BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35345331)

  • 1. Deep learning quantification of vascular pharmacokinetic parameters in mouse brain tumor models.
    Arledge CA; Sankepalle DM; Crowe WN; Liu Y; Wang L; Zhao D
    Front Biosci (Landmark Ed); 2022 Mar; 27(3):99. PubMed ID: 35345331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer Learning Approach to Vascular Permeability Changes in Brain Metastasis Post-Whole-Brain Radiotherapy.
    Arledge CA; Crowe WN; Wang L; Bourland JD; Topaloglu U; Habib AA; Zhao D
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
    Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
    J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dependence of DCE-MRI biomarker values on analysis algorithm.
    Ng CS; Wei W; Bankson JA; Ravoori MK; Han L; Brammer DW; Klumpp S; Waterton JC; Jackson EF
    PLoS One; 2015; 10(7):e0130168. PubMed ID: 26208254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient estimation of pharmacokinetic parameters from breast dynamic contrast-enhanced MRI based on a convolutional neural network for predicting molecular subtypes.
    Zhang L; Fan M; Li L
    Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37983902
    [No Abstract]   [Full Text] [Related]  

  • 6. Convolutional neural network for accelerating the computation of the extended Tofts model in dynamic contrast-enhanced magnetic resonance imaging.
    Fang K; Wang Z; Li Z; Wang B; Han G; Cheng Z; Chen Z; Lan C; Zhang Y; Zhao P; Jin X; Liu Y; Bai R
    J Magn Reson Imaging; 2021 Jun; 53(6):1898-1910. PubMed ID: 33382513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of methods for determining vascular permeability and blood volume in human gliomas.
    Harrer JU; Parker GJ; Haroon HA; Buckley DL; Embelton K; Roberts C; Balériaux D; Jackson A
    J Magn Reson Imaging; 2004 Nov; 20(5):748-57. PubMed ID: 15503330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of pharmacokinetic parameters from DCE-MRI by extracting long and short time-dependent features using an LSTM network.
    Zou J; Balter JM; Cao Y
    Med Phys; 2020 Aug; 47(8):3447-3457. PubMed ID: 32379942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convolutional Neural Networks for Direct Inference of Pharmacokinetic Parameters: Application to Stroke Dynamic Contrast-Enhanced MRI.
    Ulas C; Das D; Thrippleton MJ; Valdés Hernández MDC; Armitage PA; Makin SD; Wardlaw JM; Menze BH
    Front Neurol; 2018; 9():1147. PubMed ID: 30671015
    [No Abstract]   [Full Text] [Related]  

  • 11. Perfusion MRI grading diffuse gliomas: Impact of permeability parameters on molecular biomarkers and survival.
    Hilario A; Hernandez-Lain A; Sepulveda JM; Lagares A; Perez-Nuñez A; Ramos A
    Neurocirugia (Astur : Engl Ed); 2019; 30(1):11-18. PubMed ID: 30143443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the Reliability of Pharmacokinetic Parameters at Dynamic Contrast-enhanced MRI in Astrocytomas: A Deep Learning Approach.
    Choi KS; You SH; Han Y; Ye JC; Jeong B; Choi SH
    Radiology; 2020 Oct; 297(1):178-188. PubMed ID: 32749203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VTDCE-Net: A time invariant deep neural network for direct estimation of pharmacokinetic parameters from undersampled DCE MRI data.
    Rastogi A; Dutta A; Yalavarthy PK
    Med Phys; 2023 Mar; 50(3):1560-1572. PubMed ID: 36354289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
    Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC
    Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized time-resolved imaging of contrast kinetics (TRICKS) in dynamic contrast-enhanced MRI after peptide receptor radionuclide therapy in small animal tumor models.
    Haeck J; Bol K; Bison S; van Tiel S; Koelewijn S; de Jong M; Veenland J; Bernsen M
    Contrast Media Mol Imaging; 2015; 10(6):413-20. PubMed ID: 25995102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of arterial input function selection on kinetic parameters in brain dynamic contrast-enhanced MRI.
    Keil VC; Mädler B; Gieseke J; Fimmers R; Hattingen E; Schild HH; Hadizadeh DR
    Magn Reson Imaging; 2017 Jul; 40():83-90. PubMed ID: 28438713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A deep dive into understanding tumor foci classification using multiparametric MRI based on convolutional neural network.
    Zong W; Lee JK; Liu C; Carver EN; Feldman AM; Janic B; Elshaikh MA; Pantelic MV; Hearshen D; Chetty IJ; Movsas B; Wen N
    Med Phys; 2020 Sep; 47(9):4077-4086. PubMed ID: 32449176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An extended vascular model for less biased estimation of permeability parameters in DCE-T1 images.
    Nejad-Davarani SP; Bagher-Ebadian H; Ewing JR; Noll DC; Mikkelsen T; Chopp M; Jiang Q
    NMR Biomed; 2017 Jun; 30(6):. PubMed ID: 28211961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
    Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
    Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of DCE-MRI parameters for brain tumors through implementation of physiologically-based pharmacokinetic model approaches for Gd-DOTA.
    Spanakis M; Kontopodis E; Van Cauter S; Sakkalis V; Marias K
    J Pharmacokinet Pharmacodyn; 2016 Oct; 43(5):529-47. PubMed ID: 27647272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.